Seeing Is Believing
Currently out of the existing stock ratings of James Quigley, 28 are a HOLD (68.29%), 11 are a BUY (26.83%), 2 are a SELL (4.88%).
Analyst James Quigley works at MORGAN STANLEY with a stock forecast success ratio of 58.21% fulfilled within 184.5 days on average.
James Quigley’s has documented 75 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GLPG, Galapagos NV ADR at 07-Mar-2024.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/13/2023. The price target of $24 was fulfilled within 30 days with a profit of $9.02 (60.21%) receiving and performance score of 20.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
17
$-1.15 (-6.34%)
17
2 months 15 days ago
3/3 (100%)
$-0.27 (-1.56%)
96
Hold
9.2
3 months 4 days ago
4/10 (40%)
$2.7 (41.54%)
490
Buy
8.5
$-9.65 (-53.17%)
10
4 months 15 days ago
2/7 (28.57%)
$0.92 (12.14%)
106
Buy
8.5
$-9.65 (-53.17%)
10
4 months 15 days ago
2/2 (100%)
$0.92 (12.14%)
106
Hold
4.75
$-13.1 (-73.39%)
4 months 29 days ago
1/2 (50%)
$0.2 (4.40%)
5
Which stock is James Quigley is most bullish on?
Which stock is James Quigley is most reserved on?
What Year was the first public recommendation made by James Quigley?